Overview

Subject Reported Target-lesion Numeric Rating Scale Evaluation by Subjects With Plaque Psoriasis Treated With Clobex® (Clobetasol Propionate) Spray 0.05%

Status:
Completed

Trial end date:
2013-10-01

Target enrollment:

Participant gender:

Summary

The aim of this study is to investigate the utility of a technological based rating scale for assessing improvement in plaque psoriasis with Clobex spray treatment.

Phase:

Phase 4

Details

Lead Sponsor:

Galderma Laboratories, L.P.

Treatments:

Clobetasol